{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:17:48Z","timestamp":1775081868235,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.clinthera.2004.11.004","type":"journal-article","created":{"date-parts":[[2005,1,6]],"date-time":"2005-01-06T07:15:12Z","timestamp":1104995712000},"page":"1834-1844","source":"Crossref","is-referenced-by-count":13,"title":["Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients"],"prefix":"10.1016","volume":"26","author":[{"given":"Dirk R.J.","family":"Kuypers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2004.11.004_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200107150-00014","article-title":"Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients","volume":"72","author":"Squifflet","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003088-200443110-00005","article-title":"Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: A prospective study in one hundred de novo renal transplant recipients","volume":"43","author":"Kuypers","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clpt.2003.12.009","article-title":"Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-tern pharmacokinetics in de novo renal allograft recipients","volume":"75","author":"Kuypers","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00003088-198917050-00004","article-title":"Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I)","volume":"17","author":"Veng-Pedersen","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003088-198917060-00005","article-title":"Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II)","volume":"17","author":"Veng-Pedersen","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jps.2600780320","article-title":"Mean time parameters dealing with the tissue distribution of drugs: Limitations and extensions","volume":"78","author":"Veng-Pedersen","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2004.11.004_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00002018-200225100-00003","article-title":"Drug interactions with tacrolimus","volume":"25","author":"van Gelder","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2004.11.004_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2004.11.004_bib12","first-page":"15","article-title":"A derivation of mean residence time","author":"Becker","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/bdd.2510080110","article-title":"Definition of mean residence times in pharmacokinetics","volume":"8","author":"Cutler","year":"1987","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinthera.2004.11.004_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8240(02)00096-4","article-title":"Mean residence times in linear compartmental systems. Symbolic formulae for their direct evaluation","volume":"65","author":"Garcia-Meseguer","year":"2003","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.clinthera.2004.11.004_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0169-409X(01)00119-3","article-title":"Non-compartmentally-based pharmacokinetic modeling","volume":"48","author":"Veng-Pedersen","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.clinthera.2004.11.004_bib16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/jps.20073","article-title":"Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination","volume":"93","author":"Berezhkovskiy","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2004.11.004_bib17","first-page":"487","article-title":"Cyclosporine pharmacokinetics in pancreas transplant recipients","volume":"20","author":"Munda","year":"1988"},{"key":"10.1016\/j.clinthera.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0091270003254797","article-title":"Chronopharmacokinetics of tacrolimus in kidney transplant recipients: Occurrence of acute rejection","volume":"43","author":"Tada","year":"2003","journal-title":"J Clin Pharroacol"},{"key":"10.1016\/j.clinthera.2004.11.004_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","article-title":"Validation of methods to study the distribution and protein binding of tacrolimus in human blood","volume":"46","author":"Zahir","year":"2001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.clinthera.2004.11.004_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/bdd.396","article-title":"The relationships between half-life (t1\/2) and mean residence time (MRT) in the twocompartment open body model","volume":"25","author":"Sobol","year":"2004","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinthera.2004.11.004_bib21","first-page":"1261","article-title":"Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation","volume":"30","author":"Undre","year":"1998"},{"key":"10.1016\/j.clinthera.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jps.10539","article-title":"Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linearpharmacokinetics","volume":"93","author":"Berezhkovskiy","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2004.11.004_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","article-title":"Factors affecting variability in distribution of tacrolimus in liver transplant recipients","volume":"57","author":"Zahir","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2004.11.004_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007691-200208000-00008","article-title":"Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay","volume":"24","author":"Kuzuya","year":"2002","journal-title":"Ther Drug Monit"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T05:56:01Z","timestamp":1548827761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0149291804803473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["0149291804803473"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2004.11.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}